review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Lynne McNamara | Q55070042 |
Mhairi Maskew | Q56521913 | ||
Adrian M. Di Bisceglie | Q87445433 | ||
P2093 | author name string | Cindy Firnhaber | |
Doreen Schulze | |||
Anne Reyneke | |||
P2860 | cites work | The evolution of hepatitis B virus serological patterns and the clinical relevance of isolated antibodies to hepatitis B core antigen in HIV infected patients | Q45732718 |
Increased detection of HBV DNA in HBsAg-positive and HBsAg-negative South African HIV/AIDS patients enrolling for highly active antiretroviral therapy at a Tertiary Hospital. | Q54498258 | ||
Young peopleʼs sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey | Q59153647 | ||
Prevalence of hepatitis B virus infection among black children in Soweto | Q34286212 | ||
The prevalence of hepatitis B co-infection in a South African urban government HIV clinic | Q34432918 | ||
Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa | Q34442006 | ||
Occult hepatitis B virus infection in patients with isolated core antibody and HIV co-infection in an urban clinic in Johannesburg, South Africa | Q34468872 | ||
Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program | Q37161725 | ||
Geographic distribution of human immunodeficiency virus in South Africa. | Q37331590 | ||
Increased exposure to hepatitis B virus infection in HIV-positive South African antenatal women | Q38926501 | ||
Hepatitis B and C virus infections and liver function in AIDS patients at Chris Hani Baragwanath Hospital, Johannesburg | Q39187042 | ||
Preimmunization epidemiology of hepatitis B virus infection in South African children | Q39508435 | ||
Frequent detection of hepatitis B virus variants associated with lamivudine resistance in treated South African patients infected chronically with different HBV genotypes | Q43570104 | ||
Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. | Q44260228 | ||
Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. | Q44441066 | ||
Occult hepatitis B in HIV-infected patients | Q44949253 | ||
Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection | Q45156938 | ||
High risk of occult hepatitis B virus infection in HIV-positive patients from South Africa | Q45459144 | ||
P433 | issue | 3 Pt B | |
P921 | main subject | South Africa | Q258 |
anti-retroviral agent | Q50430310 | ||
P304 | page(s) | 499-503 | |
P577 | publication date | 2010-01-01 | |
P1433 | published in | Antiviral Therapy | Q4775353 |
P1476 | title | HIV-HBV coinfection among South African patients receiving antiretroviral therapy | |
P478 | volume | 15 |
Q38553056 | Current treatment of hepatitis B virus infections |
Q54988709 | HBV and HIV viral load but not microbial translocation or immune activation are associated with liver fibrosis among patients in South Africa. |
Q38651617 | HBV infection in untreated HIV-infected adults in Maputo, Mozambique. |
Q40187537 | HBV influence on Response to Antiretroviral Therapy in Horizontally HIV-HBV Coinfected Patient during Early Childhood |
Q35183973 | HIV, Hepatitis B, and Hepatitis C in Zambia |
Q92440856 | Hepatitis B sero-prevalence in children under 15 years of age in South Africa using residual samples from community-based febrile rash surveillance |
Q36293979 | Hepatitis B virus sub-genotype A1 infection is characterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in Malawi |
Q34743962 | High seroprevalence of HBV and HCV infection in HIV-infected adults in Kigali, Rwanda |
Q40083239 | Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial |
Q35063655 | Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial |
Q34982182 | Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya |
Q38602272 | Seroprevalence of Hepatitis B and Delta viruses among HIV infected population attending Antiretroviral clinic in selected health facilities in Abuja Nigeria |
Q92771949 | Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa |
Q37375386 | Slow CD4+ T-Cell Recovery in Human Immunodeficiency Virus/Hepatitis B Virus-Coinfected Patients Initiating Truvada-Based Combination Antiretroviral Therapy in Botswana |